BMS72 - Cancer development and immune defense (BMS72)
Summary
Samenvatting - BMS72 - Cancer development and immune defense (BMS72) Summary
8 views 0 purchase
Course
BMS72 - Cancer development and immune defense (BMS72)
Institution
Radboud Universiteit Nijmegen (RU)
Deze samenvatting bevat alle onderwerpen behandeld tijdens het master vak BMS72 - Cancer development and immune defense (stem cell biology, hematopoiesis, leukemia, ChIP, AML/MDS, clonal evolution, epigentics, histone acetylation/methylation, DNA methylation, epigenetics in cancer, NK cells, T cell...
Content
Stem cell biology...............................................................................................................................4
Normal hematopoiesis..........................................................................................................................................4
Development of leukemia.....................................................................................................................................4
Targeted therapy...................................................................................................................................................5
Clonal evolution in myeloid malignancies..........................................................................................5
Mutations and hematopoiesis..............................................................................................................................5
Clonal hematopoiesis of indeterminate potential (ChIP).....................................................................................6
Biomarkers in AML/MDS.......................................................................................................................................6
Clonal evolution in MDS/AML...............................................................................................................................7
Epigenetics........................................................................................................................................7
What is epigenetics?.............................................................................................................................................7
How is gene expression regulated?.......................................................................................................................7
Histone acetylation..........................................................................................................................................7
DNA methylation.............................................................................................................................................8
Epigenetics and cancer..........................................................................................................................................8
Histone methylation – EZH2............................................................................................................................8
DNA methylation – DNMT3a and TET2...........................................................................................................9
Refreshment immunology...............................................................................................................10
NK cells................................................................................................................................................................10
Dendritic cells......................................................................................................................................................10
T cells...................................................................................................................................................................11
Immune therapy..............................................................................................................................12
Allogeneic stem cell transplantation...................................................................................................................12
CAR T cell therapy...............................................................................................................................................13
Modulation of the tumor microenvironment..................................................................................14
The cancer-immunity cycle.................................................................................................................................14
Cancer immunoediting........................................................................................................................................14
The cancer immunogram....................................................................................................................................16
Stem cell biology
Normal hematopoiesis
Hematopoietic stem cells (HSCs) are a type of stem cell responsible for forming blood cells. These cells remain
mostly in a “quiescent” or inactive state, dividing only about once every 25 to 50 weeks. This slow division rate
is key to preserving them throughout a person’s life, helping protect them from mutations that could arise from
frequent cell division. Because of this low division frequency, HSCs can function and remain viable over an
individual's entire lifetime.
Cells express unique combinations of molecules on their membrane and in
their cytoplasm (e.g. adhesion molecules, growth factor receptors,
transcription factors, effector molecules in granules, etc). The expression of
these molecules can be studied using fluorochrome-labeled (monoclonal)
antibodies, which can be detected by flow cytometry.
During their maturation, hematopoietic cells express proteins on their cell
membrane (so-called CD markers) and the composition of these proteins
depends on the developmental stage the cell is in. Hematopoietic stem cells
express the surface molecule CD34 on their cell membrane and are CD38 -.
Progenitor cells are CD34+CD38+ and matured blood cells are CD34-CD38+. The combination of the following
markers is typically used to identify HSC populations: CD34+, CD38-, Thy-1+, c-kit+, IL-3R-.
↪ “The” stem cell cannot be identified just by cell surface markers; we can only identify populations.
Development of leukemia
Leukemia is a cancer caused by genetic mutations that disrupt the balance of
cell proliferation, differentiation, and apoptosis. It results in more than 20%
immature cells, or blasts, in the bone marrow. Leukemia types are broadly
categorized as myeloid or lymphoid and as acute (rapid progression) or chronic
(slower progression). Initially, leukemia subtypes were classified based on cell
morphology, but nowadays genetic classification is included.
Leukemia treatment aims for a cure, typically starting with two rounds of
intensive chemotherapy, followed by a third round in some cases, depending
on patient fitness. The only curative treatment for leukemia is
autologous/allogeneic transplantation.
Leukemia develops through the sequential accumulation of mutations resulting in the
formation of leukemia initiating stem cells. These cells differentiate towards progenitor cells that proliferate
growth factor independent and that are blocked in their differentiation (differentiation block). Leukemia is a
multistep process in which more than 1 error must arise in the cell's genetic material. Genes that are mutated
in leukemia can be classified in four major biological groups:
Growth factor receptors
Signal transduction molecules
Gene expression regulation (transcription factors, epigenetic regulators, RNA splicing factors or
chromatin organization)
Apoptosis
↪ For full blown leukemia development usually a combination of mutations in 2-3 genes from different
categories is necessary.
Normal stem cell: generation of all mature blood cell types, life long.
Cancer stem cell: continuous generation of more differentiated immature leukemia blasts.
Leukemia likely originates from an early stem cell. When immature blast cells are transplanted into mice, they
seldom lead to leukemia. In contrast, early leukemia stem cells (LSCs) frequently cause leukemia upon
transplantation, indicating that LSCs are more likely to initiate the disease. However, it does not imply that the
cancer stem cell is directly derived from a normal stem cell, it can also be derived from a more mature cell.
4
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller StudentRU07. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $8.55. You're not tied to anything after your purchase.
